Skip to main content

Table 2 Laboratory related characteristics, 2020

From: Incidence and determinants of adverse outcomes among women who were managed for eclampsia in the University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia

Characteristics

Frequency

Percent

Hematocrit

 No anemia (≥ 33.0%)

192

83.1

 Mild anemia (30.0–32.9%)

24

10.4

 Moderate anemia (21.0–29.9%)

13

5.6

 Severe anemia (<  21.0%)

2

.9

Platelet count

 Platelet count < 50,000 cells/mm3

20

8.7

 Platelet count 50,000–99,000 cells/mm3

31

13.4

 Platelet count 100,000–149,000 cells/mm3

44

19.0

 Platelet count > 150,000 cells/mm3

136

58.9

SGOT

 ≤ 70 u/L

139

60.2

 71–175 u/L

48

20.8

 176–350 u/L

12

5.2

 351–525 u/L

12

5.2

 ≥ 526 u/L

9

3.9

 Othera

11

4.8

SGPT

 ≤ 70 u/L

168

72.7

 71–175 u/L

25

10.8

 176–350 u/L

17

7.4

 351–525 u/L

3

1.3

 ≥ 526 u/L

6

2.6

 Othera

12

5.2

BIL-T

 ≤ 1 mg/dl

10

4.3

 1.10–5.99 mg/dl

1

.4

 ≥ 6.00 mg/dl

5

2.2

 Othera

215

93.1

LDH

 ≤ 600 u/L

2

.9

 ≥ 601 u/L

10

4.3

 Othera

219

94.8

Creatinine

 ≤ 1.5 mg/dl

200

86.6

 1.6–2.0 mg/dl

5

2.2

 2.1–2.9 mg/dl

6

2.6

  ≥ 3.00 mg/dl

8

3.5

 Othera

12

5.2

  1. Key: SGOT Serum Glutamic Oxaloacetic Transaminase, SGPT Serum Glutamic Pyruvic Transaminase, BIL-T Total Bilirubin, LDH Lactic Acid Dehydrogenase; a = missing values or status is not known